| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvalent, Inc. (NUVL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. NUVL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.38M | $170.66M | - | |
| CEO | 324.9K | $40.10M | - | |
| CFO | 99.2K | $12.25M | - | |
| Other | 86.8K | $10.72M | -5,500 | |
| Other | 83.4K | $10.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Shair Matthew45 | Director | Sell | 60,000 | $100.26 | $6,015,464.36 | -1.8% | +4.7% | - | |
| Oct 20, 2025 | Miller Deborah Ann | Chief Legal Officer | Sale+OE | 5,000 | $94.91 | $474,550.00 | -9.2% | +8.1% | - | |
| Oct 16, 2025 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $90.63 | $2,447,020.92 | -2.6% | +19.3% | - | |
| Oct 16, 2025 | Miller Deborah Ann | Chief Legal Officer | Sale+OE | 28,000 | $90.72 | $2,540,289.73 | -11.7% | +19.3% | - | |
| Oct 15, 2025 | Pelish Henry E.61 | Chief Scientific Officer | Sale+OE | 14,205 | $90.04 | $1,279,018.20 | -17.7% | +12.9% | - | |
| Oct 15, 2025 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 1,683 | $85.57 | $144,014.31 | -2.7% | +12.9% | - | |
| Oct 14, 2025 | Pelish Henry E.61 | Chief Scientific Officer | Sale+OE | 10,070 | $88.84 | $894,577.89 | -3.7% | +17.1% | - | |
| Oct 14, 2025 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 40,000 | $87.36 | $3,494,303.10 | -8.0% | +17.1% | - | |
| Oct 1, 2025 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 20,000 | $85.48 | $1,709,511.80 | -13.8% | +21.6% | - | |
| Sep 30, 2025 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 27,588 | $85.05 | $2,346,255.88 | -18.3% | +17.7% | - |